Speech-Language Pathologists in Chesnee, SC Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Mrs. Mary Rebecca Reed, M.S.-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3231 Old Furnace Rd, Chesnee, SC 29323 Phone: 864-578-0128 Fax: 864-515-5198 |
Mrs. Jennifer F. Praytor Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Cooley Springs School Rd, Chesnee, SC 29323 Phone: 864-592-1211 |
Melissa Nicholson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3231 Old Furnace Rd, Chesnee, SC 29323 Phone: 864-578-0128 |
Ms. Donna Wright, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1951 River Oak Rd, Chesnee, SC 29323 Phone: 864-253-5700 Fax: 864-253-5701 |
Mrs. Laura Fisher Hodge, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3231 Old Furnace Rd, Chesnee, SC 29323 Phone: 864-578-0128 |
News Archive
New research may contribute to diagnostics of cancer
A team of researchers from the Institute of Materials Science at Kaunas University of Technology, Lithuania together with colleagues from Japan and Latvia came up with a method that forces over 300 million metal nanoparticles to self-assemble into regular structures, which enhance their interaction with light by orders of magnitude.
ACR receives grant to focus on projects that reduce health disparities
The American College of Rheumatology's new program, Uniting Collaborators for Innovation, was named one of five recipients of the American Society of Association Executives Foundation Innovation Grants Program, which awards $10,000 to programs that demonstrate engagement in innovation efforts within the association community. UCOIN is being developed by the ACR's Collaborative Initiatives department as a platform for member-led projects that reduce health disparities.
Monocytes could be a key player in sarcoidosis pathogenesis, study shows
The cause of the inflammatory lung disease sarcoidosis is unknown.
Westaim announces completion of second and final tranche of Subscription Receipts private placement
The Westaim Corporation announced that it has completed the second and final tranche of its private placement of subscription receipts (Subscription Receipts) with the sale today of 3,255,000 Subscription Receipts at a purchase price of $0.50 each for gross proceeds of $1,627,500 bringing the aggregate gross proceeds of the Subscription Receipt financing to $275,000,000. The terms of the Subscription Receipts and details regarding the initial tranche can be found in the Company's press release dated February 9, 2010.
› Verified 3 days ago